We are live on
!
Find out more
CTA
Carillon Tower Advisers Portfolio holdings
AUM
$16.4B
1-Year Est. Return
64.75%
This Fund
S&P 500
This Quarter
Est. Return
+25.67%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.4B
AUM Growth
+$8.92B
(+119%)
Cap. Flow
+$6.38B
Cap. Flow
% of AUM
38.87%
Top 10 Holdings %
Top 10 Hldgs %
11.97%
Holding
501
New
64
Increased
117
Reduced
241
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinterest
PINS
|
+$181M |
| 2 |
CrowdStrike
CRWD
|
+$173M |
| 3 |
RingCentral
RNG
|
+$166M |
| 4 |
Synopsys
SNPS
|
+$158M |
| 5 |
WCN
Waste Connections
WCN
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Q2 Holdings
QTWO
|
+$278M |
| 2 |
AJRD
Aerojet Rocketdyne Holdings
AJRD
|
+$67.6M |
| 3 |
Entegris
ENTG
|
+$54M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$31.6M |
| 5 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.21% |
| 2 | Healthcare | 20.91% |
| 3 | Industrials | 14.05% |
| 4 | Consumer Discretionary | 13.18% |
| 5 | Financials | 7.98% |
Similar funds
GAM
CCI
SWM
LCM
HCMNY
BII
HCM
DBC
Carillon Tower Advisers's Q4 2020 Portfolio in Review
As of Q4 2020, Carillon Tower Advisers held 501 positions worth $16.4B, up 119% from $7.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Carillon Tower Advisers deployed $6.38B of net new capital in Q4 2020, opening 64 new positions and adding to 117 existing holdings. Its largest new stake was Pinterest: 3,021,131 shares worth $199M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Q2 Holdings, an estimated $278M trimmed.
- Carillon Tower Advisers's largest Q4 2020 buy was Pinterest: 3,021,131 shares worth $199M.
- Carillon Tower Advisers added most to CrowdStrike in Q4 2020, an estimated $173M increase.
- Carillon Tower Advisers's biggest Q4 2020 reduction was Q2 Holdings, cutting an estimated $278M.
- Carillon Tower Advisers fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2020, selling an estimated $31.6M.
- Carillon Tower Advisers's ten largest holdings make up 12% of its $16.4B portfolio in Q4 2020.
- Carillon Tower Advisers opened 64 new positions and closed 32 in Q4 2020.
- Carillon Tower Advisers's portfolio value rose 119% quarter-over-quarter to $16.4B.
Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.